Kaplan-Meier estimates of melanoma-related mortality among 114 children

PCNT is a prognostic biomarker correlated with tumor immune microenvironment in hepatocellular carcinoma and promotes tumor progression by inhibiting cell cycle arrest

Kaplan-Meier curves for melanoma-specific survival (MSS) in the Central

Original Article

Kaplan-Meier curves for melanoma-specific survival (MSS) in European

Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial

Sebaceous carcinoma epidemiology, associated malignancies and Lynch/Muir-Torre syndrome screening in England from 2008 to 2018 - Journal of the American Academy of Dermatology

Understanding Choroidal Nevus Risk Factors for Transformation into Melanoma - ScienceDirect

Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis - The Lancet Oncology

New insights into vitamin K biology with relevance to cancer: Trends in Molecular Medicine

Introduction to the Analysis of Survival Data in the Presence of Competing Risks

Cancers, Free Full-Text

Cancers, Free Full-Text

Association of marital status with stage and survival in patients with mycosis fungoides: A population‐based study - Xing - 2021 - Cancer Medicine - Wiley Online Library

Kaplan-Meier overall survival for all stages I and II melanoma patients

5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort study - The Lancet Oncology